Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keiji Yoshioka

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|October 16, 2013
Efficacy of initial Basal-supported oral therapy with sitagliptin in untreated type 2 diabetesKeiji Yoshioka
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|November 28, 2017
Skin Autofluorescence is a Noninvasive Surrogate Marker for Diabetic Microvascular Complications and Carotid Intima-Media Thickness in Japanese Patients with Type 2 Diabetes: A Cross-sectional StudyKeiji Yoshioka
Diabetes & Vascular Disease Research|July 5, 2018
Skin autofluorescence is associated with high-sensitive cardiac troponin T, a circulating cardiac biomarker, in Japanese patients with diabetes: A cross-sectional studyKeiji Yoshioka
Internal Medicine (Tokyo, Japan)|October 9, 2010
Acute disseminated encephalomyelitis associated with meningitis due to Mycobacterium intracellulareHiroshi Okada, Keiji Yoshioka
Internal Medicine (Tokyo, Japan)|July 16, 2009
Thyrotoxicosis complicated with dysphagiaHiroshi Okada, Keiji Yoshioka
Internal Medicine (Tokyo, Japan)|December 5, 2012
Useful application of the Neuropad test for assessment of diabetic polyneuropathyKeiji Yoshioka, Hiroshi Okada
Cureus|September 15, 2025
Atrioventricular Block Caused by Carteolol Eye Drops Administered to Unilateral Eye or Bilateral Eyes: A Case ReportKeiji Yoshioka, Tatsuya Kawasaki
Diabetes Care|April 30, 2003
Beta2-adrenergic receptor polymorphism and obesity in type 2 diabetes: response to van Tilburg et alKeiji Yoshioka, Toshihide Yoshida, Toshikazu Yoshikawa
Diabetes Care|August 31, 2004
Short-term intensive insulin therapy in newly diagnosed type 2 diabetes: response to Ryan, Imes, and WallaceKeiji Yoshioka, Toshihide Yoshida, Toshikazu Yoshikawa
Diabetes Care|November 25, 2003
Glimepiride and serum adiponectin level in type 2 diabetic subjects: response to Nagasaka et alKeiji Yoshioka, Toshihide Yoshida, Toshikazu Yoshikawa
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|October 16, 2013
Efficacy of initial Basal-supported oral therapy with sitagliptin in untreated type 2 diabetesKeiji Yoshioka
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|November 28, 2017
Skin Autofluorescence is a Noninvasive Surrogate Marker for Diabetic Microvascular Complications and Carotid Intima-Media Thickness in Japanese Patients with Type 2 Diabetes: A Cross-sectional StudyKeiji Yoshioka
Diabetes & Vascular Disease Research|July 5, 2018
Skin autofluorescence is associated with high-sensitive cardiac troponin T, a circulating cardiac biomarker, in Japanese patients with diabetes: A cross-sectional studyKeiji Yoshioka
Internal Medicine (Tokyo, Japan)|October 9, 2010
Acute disseminated encephalomyelitis associated with meningitis due to Mycobacterium intracellulareHiroshi Okada, Keiji Yoshioka
Internal Medicine (Tokyo, Japan)|July 16, 2009
Thyrotoxicosis complicated with dysphagiaHiroshi Okada, Keiji Yoshioka
Internal Medicine (Tokyo, Japan)|December 5, 2012
Useful application of the Neuropad test for assessment of diabetic polyneuropathyKeiji Yoshioka, Hiroshi Okada
Cureus|September 15, 2025
Atrioventricular Block Caused by Carteolol Eye Drops Administered to Unilateral Eye or Bilateral Eyes: A Case ReportKeiji Yoshioka, Tatsuya Kawasaki
Diabetes Care|April 30, 2003
Beta2-adrenergic receptor polymorphism and obesity in type 2 diabetes: response to van Tilburg et alKeiji Yoshioka, Toshihide Yoshida, Toshikazu Yoshikawa
Diabetes Care|August 31, 2004
Short-term intensive insulin therapy in newly diagnosed type 2 diabetes: response to Ryan, Imes, and WallaceKeiji Yoshioka, Toshihide Yoshida, Toshikazu Yoshikawa
Diabetes Care|November 25, 2003
Glimepiride and serum adiponectin level in type 2 diabetic subjects: response to Nagasaka et alKeiji Yoshioka, Toshihide Yoshida, Toshikazu Yoshikawa
Pageof 4